Literature DB >> 20636341

A multi-centre, prospective, clinical in-market evaluation to assess the performance of Opsite™ Post-Op Visible dressings.

Gillian O'Brien1, Karen Buckley, Geert Vanwalleghem, Dirk Vanrenterghem, Hussein Dharma, Rachael L Winter, Jude Douglass.   

Abstract

The aim of this study was to assess the performance of Opsite™ Post-Op Visible as a post-surgical dressing in a typical clinical setting. In this multi-centre clinical evaluation, patients who underwent clean surgery were treated with Opsite Post-Op Visible dressing. Duration of dressing wear, visibility through the dressing and ability to handle exudate were assessed and the product was rated in comparison with those normally used. A total of 64 patients were recruited. Mean wear time was 4·5 days. Exudate management was rated very good or good at 96% of assessments. Visibility of the incision site was rated as very good or good at 72%, and as acceptable at 24%, of assessments. Patient comfort was rated very comfortable (63%) or comfortable (37%) at all assessments. Dressings were generally rated as satisfactory or exceeding expectations with clinicians stating that the Opsite Post-Op Visible dressing was better than the dressing they routinely used for 92% of patients. Opsite Post-Op Visible dressing is an innovative dressing combining good visibility with exudate management and patient comfort. It was found to have adequate wear time, visibility and exudate management properties making it suitable for use on a variety of surgical incision sites. © Smith and Nephew Medical Ltd. Journal Compilation.
© 2010 The authors Journal Compilation © 2010 Blackwell Publishing Ltd and Medicalhelplines.com Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20636341      PMCID: PMC7951712          DOI: 10.1111/j.1742-481X.2010.00689.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  2 in total

1.  The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs.

Authors:  K B Kirkland; J P Briggs; S L Trivette; W E Wilkinson; D J Sexton
Journal:  Infect Control Hosp Epidemiol       Date:  1999-11       Impact factor: 3.254

2.  Adverse impact of surgical site infections in English hospitals.

Authors:  R Coello; A Charlett; J Wilson; V Ward; A Pearson; P Borriello
Journal:  J Hosp Infect       Date:  2005-06       Impact factor: 3.926

  2 in total
  4 in total

1.  Usefulness of an enhanced recovery after surgery protocol for perioperative management following open repair of an abdominal aortic aneurysm.

Authors:  Wataru Tatsuishi; Takayuki Kohri; Kojiro Kodera; Ryota Asano; Go Kataoka; Sayaka Kubota; Kiyoharu Nakano
Journal:  Surg Today       Date:  2012-07-14       Impact factor: 2.549

Review 2.  Clinical applications of naturally derived biopolymer-based scaffolds for regenerative medicine.

Authors:  Whitney L Stoppel; Chiara E Ghezzi; Stephanie L McNamara; Lauren D Black; David L Kaplan
Journal:  Ann Biomed Eng       Date:  2014-12-24       Impact factor: 3.934

3.  Open-label clinical trial comparing the clinical and economic effectiveness of using a polyurethane film surgical dressing with gauze surgical dressings in the care of post-operative surgical wounds.

Authors:  Ana Abejón Arroyo; Pabló López Casanova; José Verdú Soriano; Joan-Enric Torra I Bou
Journal:  Int Wound J       Date:  2013-06-07       Impact factor: 3.315

4.  Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial.

Authors:  Raymond J Chan; Sarah Northfield; Emily Larsen; Gabor Mihala; Amanda Ullman; Peter Hancock; Nicole Marsh; Nicole Gavin; David Wyld; Anthony Allworth; Emily Russell; Md Abu Choudhury; Julie Flynn; Claire M Rickard
Journal:  Trials       Date:  2017-10-04       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.